Rami AL BATRAN

Dr. Rami Al Batran is an **Associate Professor** at the **Faculté de pharmacie, Université de Montréal**, leading research on energy metabolism, obesity, diabetes, and cardiovascular disease. His lab investigates how metabolic perturbations in obesity contribute to comorbidities like type 2 diabetes and cardiovascular disorders, with a focus on therapeutic interventions targeting ketone body metabolism.

His research interests include:

• Obesity-induced metabolic dysregulation
• Ketone body metabolism in disease
• Pharmacological modulation of energy pathways
• Animal models of diabetes and cardiovascular pathology

He has secured funding from prestigious institutions such as the **Fonds de recherche du Québec - Santé (FRQS)** and **Canadian Institutes of Health Research (CIHR)**. Notable awards include the **KRESCENT New Investigator Award** and **Research Scholars Junior 1** grant. His work spans experimental models and clinical applications, with a lab located at the Jean Coutu Pavilion.

Grants/Projects:

• Exploring Hepatoprotective Actions of SGLT2 Inhibitors (IRSC-funded)
• Medium Chain Triglycerides and Ketogenesis (CRSNG-funded)
• Ketogenic Diet Effects on Atherosclerosis (Fondation des maladies du cœur)

Awards:

• Research Scholars Junior 1 (FRQS)
• KRESCENT New Investigator Award
• CIHR Post-Doctoral Fellowship

Lab Activities: The Al Batran Lab recruits PhD candidates in molecular biology/biotechnology, emphasizing projects on ketone metabolism in diabetic kidney disease. The lab employs mouse genetics, pharmacological tools, and state-of-the-art techniques to study metabolic pathways.